Reference
Holmoy T, et al. Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. BMC Research Notes 12: 497, No. 1, 12 Aug 2019. Available from: URL: http://doi.org/10.1186/s13104-019-4507-6
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1790, 21 (2020). https://doi.org/10.1007/s40278-020-74640-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74640-x